High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$1.4M
$1,411,220
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
|
ARQT
S
Arcutis Biotherapeutics, Inc.
Burnett Patrick
• Officer • See Remarks
Sell to Cover
2026-03-02
$153,629
|
||||||
| ARQT |
Arcutis Biotherapeutics, Inc.
|
Officer • See Remarks
Sell to Cover
|
2026-03-02 | $153,629 | S | Form 4 |
|
ARQT
S
Arcutis Biotherapeutics, Inc.
Burnett Patrick
• Officer • See Remarks
Sell to Cover
2026-03-02
$4,690
|
||||||
| ARQT |
Arcutis Biotherapeutics, Inc.
|
Officer • See Remarks
Sell to Cover
|
2026-03-02 | $4,690 | S | Form 4 |
|
ARQT
S
Arcutis Biotherapeutics, Inc.
Burnett Patrick
• Officer • See Remarks
10b5-1 SellΔOwn -10.8%
2026-02-04
$252,748
|
||||||
| ARQT |
Arcutis Biotherapeutics, Inc.
|
Officer • See Remarks
10b5-1 SellΔOwn -10.8%
|
2026-02-04 | $252,748 | S | Form 4 |
|
ARQT
S
Arcutis Biotherapeutics, Inc.
Burnett Patrick
• Officer • See Remarks
Sell to Cover
2026-02-02
$93,707
|
||||||
| ARQT |
Arcutis Biotherapeutics, Inc.
|
Officer • See Remarks
Sell to Cover
|
2026-02-02 | $93,707 | S | Form 4 |
|
ARQT
M
Arcutis Biotherapeutics, Inc.
Burnett Patrick
• Officer • See Remarks
Other
2025-12-15
$41,860
|
||||||
| ARQT |
Arcutis Biotherapeutics, Inc.
|
Officer • See Remarks
Other
|
2025-12-15 | $41,860 | M | Form 4 |
|
ARQT
S
Arcutis Biotherapeutics, Inc.
Burnett Patrick
• Officer • See Remarks
10b5-1 SellΔOwn -10.5%
2025-12-15
$332,851
|
||||||
| ARQT |
Arcutis Biotherapeutics, Inc.
|
Officer • See Remarks
10b5-1 SellΔOwn -10.5%
|
2025-12-15 | $332,851 | S | Form 4 |
|
ARQT
M
Arcutis Biotherapeutics, Inc.
Burnett Patrick
• Officer • See Remarks
Equity Compensation
2025-12-15
$0
|
||||||
| ARQT |
Arcutis Biotherapeutics, Inc.
|
Officer • See Remarks
Equity Compensation
|
2025-12-15 | $0 | M | Form 4 |
|
ARQT
S
Arcutis Biotherapeutics, Inc.
Burnett Patrick
• Officer • See Remarks
10b5-1 SellΔOwn -14.9%
2025-11-06
$417,145
|
||||||
| ARQT |
Arcutis Biotherapeutics, Inc.
|
Officer • See Remarks
10b5-1 SellΔOwn -14.9%
|
2025-11-06 | $417,145 | S | Form 4 |
|
ARQT
M
Arcutis Biotherapeutics, Inc.
Burnett Patrick
• Officer • See Remarks
Other
2025-11-06
$62,790
|
||||||
| ARQT |
Arcutis Biotherapeutics, Inc.
|
Officer • See Remarks
Other
|
2025-11-06 | $62,790 | M | Form 4 |
|
ARQT
S
Arcutis Biotherapeutics, Inc.
Burnett Patrick
• Officer • See Remarks
10b5-1 Sell
2025-11-05
$91,643
|
||||||
| ARQT |
Arcutis Biotherapeutics, Inc.
|
Officer • See Remarks
10b5-1 Sell
|
2025-11-05 | $91,643 | S | Form 4 |
|
ARQT
S
Arcutis Biotherapeutics, Inc.
Burnett Patrick
• Officer • See Remarks
Sell to Cover
2025-11-03
$381
|
||||||
| ARQT |
Arcutis Biotherapeutics, Inc.
|
Officer • See Remarks
Sell to Cover
|
2025-11-03 | $381 | S | Form 4 |
|
ARQT
S
Arcutis Biotherapeutics, Inc.
Burnett Patrick
• Officer • See Remarks
Sell to Cover
2025-11-03
$64,425
|
||||||
| ARQT |
Arcutis Biotherapeutics, Inc.
|
Officer • See Remarks
Sell to Cover
|
2025-11-03 | $64,425 | S | Form 4 |